Elston MS, Boyle V, Conaglen JV, et al. Genetic testing for familial hyperaldosteronism type 1 in Aotearoa/New Zealand. Intern Med J. 2024;54(11):1814-1820. doi:10.1111/ imj.16511.

Mulatero P, Araujo-Castro M, Pacak K, et al. Familial hyperaldosteronism: an European Reference Network on Rare Endocrine Conditions clinical practice guideline. Eur J Endocrinol. 2024;190(4):G1-G12. doi:10.1093/ejendo/lvae029

Zeman J, Veldhuisen DJ, Kamilaris C, et al. Glucocorticoid Remediable Aldosteronism in a Family with a Strong History of Cerebral Aneurysms and Hypertension. Prague Med Rep. 2025;126(3):151-154. doi:10.14712/23362936.2025.23.

United Nations. World urbanization prospects: the 2018 revision [Internet]. New York: United Nations; 2018 [cited 2023 Dec 9]. Available from: https://population.un.org/wup

Caragliu A, Del Bo C, Nijkamp P. Smart cities in the innovation age: key technologies and impacts. Cities. 2022;126:103637. https://doi.org/10.1016/j.cities.2022.103637

Townsend AM. Smart cities: big data, civic hackers, and the quest for a new utopia. New York: Norton & Company; 2020.